Panel discussion

Advanced Manufacturing

Time:17:30 – 18:15

Panel title

Accelerating drug development through an advanced manufacturing network

Panel summary

The last two years of COVID-19 situation highlighted the need of a strong support of the Swiss Biotech ecosystem. One of the elements missing to develop and rapidly manufacture clinical drug candidates needed advanced technology and processes. During this panel, we will discuss how to implement a Swiss network and develop novel tools to foster the creation of innovative therapeutics in Switzerland.

Speaker information


Dr. Massimo Nobile, CEO, Swiss Biotech Center


  • Dr. Bertrand Ducrey, CEO, Debiopharm
  • Dr. Alexandre Pasini, COO, Celonic
  • Maximilien Murone, CEO, Avrion Therapeutics
  • Dr. Matthieu Stettler, Head of Mammalian Development Services Visp